Target audience: Neuroradiologists and MR scientists with an interest in advanced MR techniques and their practical implementation to address problems encountered in routine clinical practice. Purpose: Adequate grading of gliomas presents many difficulties in clinical practice but is of capital importance because treatment regimens and prognosis depend on the malignancy grade. Currently, a biopsy is warranted in order to obtain a definitive diagnosis. An imaging-based method for determining glioma grade is appealing due to its non-invasiveness. Several studies, using advanced MR techniques to grade gliomas have been published, although most of the reported results were demonstrated on a group level. In order to find acceptance in clinical practice, prospective grading of gliomas should be performed on an individual patient level with sufficient accuracy. Moreover, combining different modalities has the potential to increase diagnostic accuracy, as the different advanced MR techniques yield complementary information. In this study, it was our aim to assess the separate diagnostic performances of diffusion kurtosis imaging (DKI) [1], dynamic susceptibilityweighted MR imaging (DSC-MRI) and short echo time chemical shift imaging (CSI) for grading gliomas, and to examine if a multimodal approach could be used to improve these results.
Results: MK, MD, mean rrCBV, mean rrCBF, rDR, Lips/tCho, Lips/Cre, Myo/sum and Cre/sum showed statistically significant differences among tumor grades, with mean rrCBF as the best discriminative parameter of the perfusion parameters and MK as the best discriminative parameter of the diffusion parameters. The classification accuracy, sensitivity, specificity, negative predictive value and positive predictive value of DKI, DSC and CSI datasets for differentiating low from high grade glioma are shown in Table  1 . When considering the statistical significant DSC parameters, the performance reached 83%. Based on the DKI and CSI data the accuracy is overall lower. For the current dataset, the combination of mean rrCBF, MK and Myo/sum to grade gliomas could even show a diagnostic accuracy of 100%. Based on the ROC analysis, the mean rrCBF lowconfidence interval for the current dataset was 1.45 -1.96. For the cases where the mean rrCBF value was situated in this range (12 cases, 33%), MK was considered. The low-confidence interval for MK was 0.44 to 0.53. From these twelve cases, six MK values were in this range. In these remaining six datasets, Myo/sum was able to distinguish low from high grade gliomas in all cases based on the optimal cutoff value (0.10). Based on this decision-tree rule all case within our data were correctly graded (Fig 1) . The combination of a high mean rrCBF, a high MK and low Myo/sum was diagnostic for high grade glioma (Fig 2) . Of course, the optimal combinations and cut-offs of imaging parameters will need to be examined in a larger dataset.
Conclusion:
The most accurate parameters for determination of glioma grade were MK and mean rrCBF. However, a combination between calculated parameters could still provide a better differentiation between high-and low-grade glioma in this data set; this should be further explored in a larger study population. 
